Published in Int J Technol Assess Health Care on December 01, 2009
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (2014) 7.55
Inhibition of glycogen synthase kinase-3 alleviates Tcf3 repression of the pluripotency network and increases embryonic stem cell resistance to differentiation. Nat Cell Biol (2011) 3.25
A multidimensional conceptual framework for analysing public involvement in health services research. Health Expect (2008) 2.93
Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches. Int J Technol Assess Health Care (2003) 2.75
How to formulate research recommendations. BMJ (2006) 2.38
Carbon cost of pragmatic randomised controlled trials: retrospective analysis of sample of trials. BMJ (2009) 1.86
Teaching critical appraisal skills in healthcare settings. Cochrane Database Syst Rev (2011) 1.37
Databases and information integration for the Medicago truncatula genome and transcriptome. Plant Physiol (2005) 1.23
A systematic review of models to predict recruitment to multicentre clinical trials. BMC Med Res Methodol (2010) 1.22
Are infant size and growth related to burden of disease in adulthood? A systematic review of literature. Int J Epidemiol (2006) 1.14
European network for health technology assessment, EUnetHTA: planning, development, and implementation of a sustainable European network for health technology assessment. Int J Technol Assess Health Care (2009) 1.12
So many filters, so little time: the development of a search filter appraisal checklist. J Med Libr Assoc (2008) 1.05
The HTA core model: a novel method for producing and reporting health technology assessments. Int J Technol Assess Health Care (2009) 1.00
Health technology assessment in England and Wales. Int J Technol Assess Health Care (2004) 0.96
The completeness of intervention descriptions in published National Institute of Health Research HTA-funded trials: a cross-sectional study. BMJ Open (2014) 0.94
A common policy framework for evidence generation on promising health technologies. Int J Technol Assess Health Care (2009) 0.93
Time to publication for NIHR HTA programme-funded research: a cohort study. BMJ Open (2013) 0.90
Late incompetence of the left atrioventricular valve after repair of atrioventricular septal defects: the morphologic perspective. J Thorac Cardiovasc Surg (2006) 0.90
Guidelines for future research in constraint-induced movement therapy for children with unilateral cerebral palsy: an expert consensus. Dev Med Child Neurol (2014) 0.89
Anatomic variability in coronary arterial distribution with regard to the arterial switch procedure. Circulation (2002) 0.88
Morphologic study of the ascending aorta and aortic arch in hypoplastic left hearts: surgical implications. J Thorac Cardiovasc Surg (2007) 0.88
A series of potent CREBBP bromodomain ligands reveals an induced-fit pocket stabilized by a cation-π interaction. Angew Chem Int Ed Engl (2014) 0.88
What value health?: A review of health state values used in early technology assessments for NICE. Appl Health Econ Health Policy (2005) 0.88
The health technology assessment adaptation toolkit: description and use. Int J Technol Assess Health Care (2009) 0.88
Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA. Int J Technol Assess Health Care (2009) 0.88
Research to decrease areas of clinical uncertainty. BMJ (2011) 0.88
Development of the outflow tracts with reference to aortopulmonary windows and aortoventricular tunnels. Cardiol Young (2010) 0.87
The long road of pain: chronic pain increases perceived distance. Exp Brain Res (2008) 0.85
The effects of microgravity on nanoparticle size distributions generated by the ultrasonic reduction of an aqueous gold-chloride solution. Ultrason Sonochem (2003) 0.84
Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors. Bioorg Med Chem Lett (2010) 0.84
Health technology assessment: history and demand. J Public Health Med (2003) 0.84
Myocardial necrosis and infarction in newborns and infants. Forensic Sci Med Pathol (2013) 0.83
A pilot Internet "value of health" panel: recruitment, participation and compliance. Health Qual Life Outcomes (2006) 0.82
Inequity of use of implantable cardioverter defibrillators in England: retrospective analysis. BMJ (2005) 0.82
Discovery of small molecule human FPR1 receptor antagonists. Bioorg Med Chem Lett (2011) 0.82
Growth hormone replacement in adults and bone mineral density: a systematic review and meta-analysis. Clin Endocrinol (Oxf) (2004) 0.82
Specialist capacity in public health: are we hitting the target? Public Health (2006) 0.81
Medical justice for undocumented migrants. Lancet (2008) 0.81
The conduction system in hearts with pulmonary atresia and intact ventricular septum. Ann Thorac Surg (2003) 0.80
Self-catalyzed degradable cationic polymer for release of DNA. Biomacromolecules (2011) 0.79
Zwitterionic CRTh2 antagonists. J Med Chem (2011) 0.78
Enhancing understanding: the development of a glossary of health technology assessment adaptation terms. Int J Technol Assess Health Care (2009) 0.78
The precision of health state valuation by members of the general public using the standard gamble. Qual Life Res (2009) 0.78
Setting the future policy agenda for health technology assessment: a specialty mapping approach. Int J Technol Assess Health Care (2007) 0.78
Discovery of pyrazoles as novel FPR1 antagonists. Bioorg Med Chem Lett (2011) 0.78
Re-repair of the left atrioventricular valve in atrioventricular septal defects: the morphologic approach to the role of Gore-tex band reduction annuloplasty. Eur J Cardiothorac Surg (2009) 0.77
Assessing the international use of health technology assessments: exploring the merits of different methods when applied to the National Institute of Health Research Health Technology Assessment (NIHR HTA) programme. Int J Technol Assess Health Care (2013) 0.77
Biosensor-based approach to the identification of protein kinase ligands with dual-site modes of action. J Biomol Screen (2011) 0.76
The value of visualizing tone of voice. Logoped Phoniatr Vocol (2013) 0.76
Left ventricular outflow tract obstruction after the modified single patch repair of atrioventricular septal defects: teasing fact from fiction. Ann Thorac Surg (2010) 0.75
Registration of noncommercial randomised clinical trials: the feasibility of using trial registries to monitor the number of trials. Trials (2012) 0.75
Patient satisfaction with a Web-based patient-provider messaging system implemented across a statewide delivery system (Group Health Cooperative). AMIA Annu Symp Proc (2003) 0.75
Growth hormone therapy in children with idiopathic short stature. Arch Pediatr Adolesc Med (2002) 0.75
Funding for clinical research in the UK. Lancet (2006) 0.75
Subclinical hypothyroidism: Let's identify research questions. BMJ (2008) 0.75
Impact of discussion on preferences elicited in a group setting. Health Qual Life Outcomes (2006) 0.75
Potential benefits of using a toolkit developed to aid in the adaptation of HTA reports: a case study considering positron emission tomography (PET) and Hodgkin's disease. Health Res Policy Syst (2010) 0.75
The Southampton Consensus Guidelines for Laparoscopic Liver Surgery: From Indication to Implementation. Ann Surg (2017) 0.75
Testing the HTA core model: experiences from two pilot projects. Int J Technol Assess Health Care (2009) 0.75
Web-based toolkit to facilitate European collaboration on evidence generation on promising health technologies. Int J Technol Assess Health Care (2009) 0.75
Effect of lipophilicity modulation on inhibition of human rhinovirus capsid binders. Bioorg Med Chem Lett (2011) 0.75